Emulate is a biotechnology company advancing human-relevant research through next-generation Organ-on-a-Chip technology. Since 2014, it has developed systems that allow researchers to emulate aspects of human biology and investigate how people may respond to drugs and other interventions. The company reports more than 30 organ models featured across over 130 publications, and its Organ-Chip technology has been accepted into the FDA’s ISTAND program for drug-induced liver injury evaluation.

Emulate’s product portfolio includes the Ava Emulation System, Zoë Culture Module, and compatible stretchable, rigid, accessible, and array chips. Its models cover organs and tissues including the brain, intestine, kidney, liver, bone marrow, lung, lymphoid system, and vagina. These tools support research in areas such as toxicology, neuroscience, infectious disease, cancer, cell and gene therapy, immunology, inflammation, and the microbiome.

The company also provides research resources, including publications, application notes, seminars, webinars, blogs, protocols, and user guides. Emulate offers technical support and sales assistance, and collaborates with researchers and organizations to advance applications of organ-chip methods.